Find a Specialist by Postal Code | Page 2 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Stephan Paul, MD, JD J. W. Ruby Memorial Hospital Morgantown West Virginia United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
  • Pediatric
Nikolai Podoltsev, MD, PhD Smilow Cancer Hospital at Yale New Haven Connecticut United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jen Chin Wang, MD New York Cancer & Blood Specialists Rockville Centre New York United States
  • Acute Myeloid Leukemia (AML)
Raymond J. Hohl, MD, PhD The Pennsylvania State University School of Medicine Hershey Pennsylvania United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Matthew Fero, MD, FACP University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
Yael Kusne, MD PhD Mayo Clinic, Phoenix, AZ Phoenix Arizona United States
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Sudipto Mukherjee, MD, MPH Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Julio Alvarenga Thiebaud, MD. Department of Internal Medicine at UT Southwestern Medical Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Matthew Walter, MD Washington University - Barnes Jewish Hospital St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Abdulraheem Yacoub, MD University of Kansas Medical Center Kansas City Kansas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Thomas LeBlanc, MD, MA Duke Cancer Center Durham North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Joshua Zeidner, MD Chapel Hill North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Srinivasa Reddy Sanikommu, MD Levine Cancer Institute - Morehead Charlotte North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Marianne M Green, MD Northwestern University Feinberg School of Medicine Chicago Illinois United States
Rick J Jones, MD Johns Hopkins University Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Mariam Nawas, MD University of Chicago Chicago Illinois United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Hetty Carraway, M.D. The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Amer Zeidan, MBBS Yale University and Yale Cancer Center New Haven Connecticut United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Vinod Pullarkat, MD, MRCP City of Hope Duarte California United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Timothy Pardee, MD, PhD Wake Forest Baptist Health Comprehensive Cancer Center Winston Salem North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)